Morning Overview on MSN

Weight-loss drugs like Ozempic may quietly leave your muscles weaker, a new study warns

Millions of people taking semaglutide or tirzepatide for weight loss could be losing more than fat. A pharmacovigilance study ...

Zimmer Biomet (ZBH) Is Buying Pacira’s Iovera Device And Expanding Into Spasticity

Zimmer Biomet Holdings (NYSE:ZBH) agreed to acquire Pacira BioSciences’ FDA cleared iovera pain relief device. The agreement ...

Medicare is now covering some GLP-1 weight loss drugs for $50. Here’s what to know

The federal government has launched a new program to make GLP-1 weight loss drugs more affordable for older Americans.
BioSpace

Sarepta secures early 2027 FDA decision for Duchenne drugs, pushing past confirmatory fail

Sarepta Therapeutics is seeking to convert the accelerated approval of its therapeutic exon-skippers for Duchenne muscular dystrophy to full despite the drugs’ failure to improve motor function in a ...
News-Medical.Net

GLP-1 medications may improve long-term health for people with peripheral artery disease

GLP-1 receptor agonists (GLP-1 RA) medications were shown to reduce the number of deaths, amputations and hospitalizations ...

What older adults need to know before taking a GLP-1 medication to lose weight

Starting Wednesday, millions of Medicare-qualifying adults will have access to popular medications for weight loss at deep ...

GLP-1 medications linked to fewer deaths and amputations in people with type 2 diabetes and PAD

According to new, independent research published in the Journal of the American Heart Association, GLP-1 receptor agonist ...